![Torbjörn Larsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Torbjörn Larsson worked as Director-Pharmaceutical Development at Medivir AB. Worked as Director-Commercial Production at Aprea Therapeutics AB. Worked as Head-Chemistry, Manufacturing & Controls at Guard Therapeutics International AB from 2022 to 2026.
Former jobs include Director-Pharmaceutical Development at Medivir AB, Director-Commercial Production at Aprea Therapeutics AB, and Head-Chemistry, Manufacturing & Controls at Guard Therapeutics International AB.
Anciens postes connus de Torbjörn Larsson
| Sociétés | Poste | Fin |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Corporate Officer/Principal | 30/04/2026 |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Corporate Officer/Principal | - |
| MEDIVIR AB | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
